Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Influenza A virus vaccine H5N1 - iBio

Drug Profile

Influenza A virus vaccine H5N1 - iBio

Alternative Names: HAI-05 Influenza Vaccine; Pandemic avian influenza vaccine - iBio; Plant virus derived influenza vaccine - iBio

Latest Information Update: 28 Dec 2017

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator INB:Biotechnologies
  • Developer iBio Inc
  • Class Influenza A virus H5N1 vaccines; Influenza virus vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Influenza A virus H5N1 subtype

Most Recent Events

  • 28 Dec 2017 No recent reports of development identified for phase-I development in Influenza-A-virus-H5N1-subtype(In volunteers) in USA (IM)
  • 30 Nov 2015 Phase I development is ongoing in USA
  • 30 Nov 2015 iBio has patent protection for iBioModulator™ thermostable immunomodulator protein technology in China
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top